Chlorambucil
Bone Marrow Suppression; Teratogen
- Bone Marrow Suppression: severe
- Carcinogen in humans
- Mutagen, Teratogen: Probable in humans
- Infertility associated with this drug
MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA
- Perform weekly hematological testing to determine hemoglobin, total & differential leukocyte counts, & quantitative platelet counts. Perform WBC during the first 3 to 6 weeks of therapy, at 3 or 4 days after each weekly complete blood cell counts.
Patient Counseling Information
Package Inserts
Additional Information
Updated January 2018